Lifetime pharma ban? ‘Pharma Bro’ returns with ‘software’ company for drug discovery
Famous for skyrocketing the price of a lifesaving drug and getting into feuds with anybody and everybody on the internet and in Congress, the “Pharma Bro” is back, sort of. Instead of hiking drug prices, he claims he’s lowering the costs for those attempting to discover drugs.
Martin Shkreli has co-founded a new company, which he claims to be a “Web3 drug discovery software platform.”
That is, of course, because Shkreli received a lifetime ban from the pharmaceutical industry, a barrier that he has, as his own attorney, failed to get overturned. Yet the industry still fuels the focus of his online presence, with videos of him deriding the “lack of transparency” at Mark Cuban’s pharmacy company — which aims to reduce costs for patients — alongside other opinions and memes.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,200+ biopharma pros reading Endpoints daily — and it's free.